MCHEMX LIMITED
Executive Summary
MCHEMX LIMITED is currently a dormant micro-entity positioned within the high-tech biotechnology and pharmaceutical research sectors but has not yet begun trading or asset accumulation. Its present lack of operational activity and financial footprint place it far below typical industry benchmarks, indicating it is at a very early development stage. Success in this capital-intensive and innovation-driven sector will require substantial resource investment and strategic execution to transition from dormancy to active market participation.
View Full Analysis Report →- Legal registered address
- Holdenby Fore Street Seaton England EX12 2AD Copied!
Latest financial results as of 2 August 2025- Current assets
- £0
- Fixed assets
- £0
- Current creditors
- £0
- Shareholders funds
- £0
View full financial accounts- Current assets
- £0
- Fixed assets
- £0
- Current creditors
- £0
- Shareholders funds
- £0
- Company number
- 14809093 Copied!
Accounts
Latest annual accounts were to 30 April 2024
Next annual accounts are due by 31 January 2026
Company financial year end is on 30 April 2026
Confirmation statement
Latest confirmation statement statement dated 16 April 2025
Next statement due by 30 April 2026
Nature of business (SIC)
21100 - Manufacture of basic pharmaceutical products
71200 - Technical testing and analysis
72110 - Research and experimental development on biotechnology
74100 - specialised design activities
Latest company documents
| Date | Description |
|---|---|
| 28/04/2528 April 2025 | Confirmation statement made on 2025-04-16 with no updates |
| 16/01/2516 January 2025 | Accounts for a dormant company made up to 2024-04-30 |
| 12/05/2412 May 2024 | Confirmation statement made on 2024-04-16 with no updates |
| 30/04/2430 April 2024 | Annual accounts for year ending 30 Apr 2024 |
| 17/04/2317 April 2023 | Incorporation |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company